Latest Parkinson's Disease Foundation Stories
PPMI now recruiting individuals with genetic mutation linked to Gaucher disease NEW YORK, March 24, 2015 /PRNewswire-USNewswire/ -- The Parkinson's Progression Markers Initiative (PPMI),
Newest Leaders Driving PDF's Mission to End Parkinson's Disease NEW YORK, March 12, 2015 /PRNewswire-USNewswire/ -- The Parkinson's Disease Foundation® (PDF®) is pleased to announce
The largest grassroots Parkinson's fundraiser in the U.S.
-- DUOPA is the first and only treatment providing 16 continuous hours of carbidopa and levodopa for motor fluctuations in advanced Parkinson's disease NORTH CHICAGO, Ill., Jan.
New program will support the identification of novel drug targets to treat Parkinson's disease MOUNTAIN VIEW, Calif., Jan.
Recognizes "All the Ways Care Partners Care" During November's National Family Caregivers Month NEW YORK, Nov.
Collaboration to Expand Pioneering Education Program NEW YORK, Oct. 30, 2014 /PRNewswire-USNewswire/ -- The Parkinson's Disease Foundation® (PDF®) and the Edmond J.
Free Educational Seminars, Designed with Community Input, Provide Practical Tips for People with Parkinson's and Continuing Education for Health Professionals NEW YORK, Sept.
GRAND RAPIDS, Mich., Aug.
FPRT Bio works closely with academic leaders and research organizations to advance the use of XPro1595 in the treatment of Parkinson’s disease. Dallas, Texas
- The governor of a province or people.